unknown
Stage
2009
Founded
1
Investors
About
Formycon AG is a German biopharmaceutical company that develops high-quality biosimilar medicines. They focus on creating follow-on versions of approved biopharmaceutical drugs, primarily in ophthalmology, immunology, and other chronic diseases.
Explore Formycon AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.